Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haesook T Kim

Showing results (91-100 of 191) with videos related to

Pageof 20
Sort By:
Blood|September 9, 2008
Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantationCorey Cutler, Kristen Stevenson, Haesook T Kim, et al.
Blood|December 23, 2004
Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remissionDavid B Miklos, Haesook T Kim, Katherine H Miller, et al.
Science Translational Medicine|April 5, 2013
Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host diseaseKen-ichi Matsuoka, John Koreth, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 15, 2014
A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host diseaseAlex F Herrera, Haesook T Kim, Bhavjot Bindra, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 4, 2019
Incidence, Predictors, and Outcomes of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Reduced-Intensity Allogeneic Hematopoietic Cell TransplantationClinton Lewis, Haesook T Kim, Lindsey E Roeker, et al.
Blood Advances|January 4, 2018
Vaccination with autologous myeloblasts admixed with GM-K562 cells in patients with advanced MDS or AML after allogeneic HSCTVincent T Ho, Haesook T Kim, Natalie Bavli, et al.
American Journal of Hematology|June 13, 2025
Poor Engraftment After Posttransplant Cyclophosphamide Graft-Versus-Host DISAESE Prophylaxis in Patients With MyelofibrosisHaesook T Kim, Deborah J Liney, Kristen Rizza, et al.
Leukemia|January 25, 2021
Author Correction: Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?Gregory A Abel, Haesook T Kim, Andrew Hantel, et al.
Blood Advances|August 21, 2023
Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host diseaseHolly Wobma, Malika Kapadia, Haesook T Kim, et al.
Leukemia|November 18, 2020
Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?Gregory A Abel, Haesook T Kim, Andrew Hantel, et al.
Pageof 20

Showing results (91-100 of 191) with videos related to

Sort By:
Pageof 20
Blood|September 9, 2008
Sirolimus is associated with veno-occlusive disease of the liver after myeloablative allogeneic stem cell transplantationCorey Cutler, Kristen Stevenson, Haesook T Kim, et al.
Blood|December 23, 2004
Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remissionDavid B Miklos, Haesook T Kim, Katherine H Miller, et al.
Science Translational Medicine|April 5, 2013
Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host diseaseKen-ichi Matsuoka, John Koreth, Haesook T Kim, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 15, 2014
A phase II study of bortezomib plus prednisone for initial therapy of chronic graft-versus-host diseaseAlex F Herrera, Haesook T Kim, Bhavjot Bindra, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 4, 2019
Incidence, Predictors, and Outcomes of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Reduced-Intensity Allogeneic Hematopoietic Cell TransplantationClinton Lewis, Haesook T Kim, Lindsey E Roeker, et al.
Blood Advances|January 4, 2018
Vaccination with autologous myeloblasts admixed with GM-K562 cells in patients with advanced MDS or AML after allogeneic HSCTVincent T Ho, Haesook T Kim, Natalie Bavli, et al.
American Journal of Hematology|June 13, 2025
Poor Engraftment After Posttransplant Cyclophosphamide Graft-Versus-Host DISAESE Prophylaxis in Patients With MyelofibrosisHaesook T Kim, Deborah J Liney, Kristen Rizza, et al.
Leukemia|January 25, 2021
Author Correction: Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?Gregory A Abel, Haesook T Kim, Andrew Hantel, et al.
Blood Advances|August 21, 2023
Real-world experience with low-dose IL-2 for children and young adults with refractory chronic graft-versus-host diseaseHolly Wobma, Malika Kapadia, Haesook T Kim, et al.
Leukemia|November 18, 2020
Fit older adults with advanced myelodysplastic syndromes: who is most likely to benefit from transplant?Gregory A Abel, Haesook T Kim, Andrew Hantel, et al.
Pageof 20